Age |
median (IQR) |
38 (33-46) |
>50 years, n(%) |
30 (13) |
≤50 years, n(%) |
201 (87) |
Female |
160 (69.26) |
HIV type 1, n(%) |
221 (95.67) |
Baseline CD4 cells count |
median (IQR) |
148 (78-220) |
<200/mm3, n(%) |
158 (68.4) |
≥200/mm3, n(%) |
73 (31.6) |
Karnofsky score, median (IQR) |
90 (90-90) |
CDC Clinic stage |
stage A or B, n(%) |
172 (74.46) |
stage C, n(%) |
59 (25.54) |
Presence of opportunistic infections, n(%) |
158 (68.4) |
|
NNRTI-based regimens |
NVP-based regimen, n(%) |
192 (88.9) |
EFV-based regimen, n(%) |
24 (11.1) |
PI-based regimen, n(%) |
9 (3.9) |
3 NRTIs regimen, n(%) |
6 (2.6) |
Cotrimoxazole prophylaxis, n(%) |
208 (90) |
Socio-economic condition |
Low condition, n(%) |
185 (80.10%) |
Medium or high condition, n(%) |
46 (19.9%) |
Housing condition |
Standing, n(%) |
110 (47.7%) |
Modest, n(%) |
115 (49.8%) |
Precarious, n(%) |
6 (2.6%) |
Education |
Illiteracy or primary school level, n(%) |
137 (85.7%) |
Secondary or high school level, n(%) |
94 (40.7%) |
IQR: interquartile range |